Bioventus (BVS) Current Assets (2020 - 2026)

Bioventus' Current Assets history runs 7 years deep, the most recent figure standing at $249.8 million for Q1 2026.

• Quarterly Current Assets changed 0.18% year-over-year to $249.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $249.8 million (changed 0.18% YoY) and the FY2025 annual result came in at $272.8 million, down 1.0% from the prior year.
• Current Assets was $249.8 million for Q1 2026 at Bioventus, down from $272.8 million in the prior quarter.
• Across five years, Current Assets topped out at $308.9 million in Q2 2024 and bottomed at $245.4 million in Q2 2022.
• A 5-year average of $272.4 million and a median of $272.6 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets grew 25.78% — and 2024, when it dropped 13.85%.
• Bioventus' Current Assets stood at $272.6 million in 2022, then declined by 1.68% to $268.0 million in 2023, then gained by 2.84% to $275.6 million in 2024, then declined by 1.0% to $272.8 million in 2025, then dropped by 8.44% to $249.8 million in 2026.
• Business Quant data shows BVS's Current Assets at $249.8 million in Q1 2026, $272.8 million in Q4 2025, and $280.9 million in Q3 2025.